Tianjin, China

Hongqi Tian

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Shanghai Kechow Pharma, Inc. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hongqi Tian. Retrieved from https://idiyas.com/inventor/hongqi-tian-gbtmi1ef

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.6

ph-index = 1


Location History:

  • Shanghai, CN (2018)
  • Tianjin, CN (2016 - 2021)

Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Hongqi Tian in Radiation Protection and Cancer Treatment

Introduction

Hongqi Tian is a notable inventor based in Tianjin, China. He has made significant contributions to the fields of radiation protection and cancer treatment through his innovative research and development. With a total of 3 patents, his work has the potential to impact both medical and pharmaceutical industries.

Latest Patents

One of Hongqi Tian's latest patents is focused on an amino mercaptan compound and its preparation method for use in protection against radiation. This invention discloses a compound that effectively reduces biological damage caused by ionizing radiation. It extends the survival period and survival rate of radiated animals while significantly alleviating the side effects of radiotherapy. The low toxicity of this compound opens up new avenues for protection and treatment of ionizing radiation damage.

Another significant patent involves benzoheterocyclic compounds and their use as protein kinase inhibitors, particularly targeting Mek. These compounds are useful in treating cancers and inflammation in mammals. The patent also describes methods for preparing potential drug candidates, including benzooxazol, benzothiazol, and benzothiadiazol, which could lead to advancements in cancer therapies.

Career Highlights

Hongqi Tian is currently associated with Shanghai Kechow Pharma, Inc., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a commitment to improving health outcomes through scientific research.

Collaborations

Hongqi Tian collaborates with talented individuals such as Ying Cheng and Conghui Ji, who contribute to his research efforts and help advance his innovative projects.

Conclusion

Hongqi Tian's contributions to the fields of radiation protection and cancer treatment through his patents demonstrate his commitment to scientific advancement. His innovative work has the potential to significantly improve health outcomes and pave the way for future research in these critical areas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…